Abstract
Purpose
Since 1997, our institute has used neoadjuvant chemotherapy for intraocular retinoblastoma. However, some of the patients showed signs of recurrence months to years later. We therefore attempted to determine the prognostic factors of treatment outcomes and survival in our patients.
Methods
We reviewed 90 patients treated from 1997 to 2006. The following information was recorded: demographic and ophthalmological data, clinical classification, histopathological data, and treatment methods and outcomes.
Results
Enucleation was avoided in two of 57 eyes in the unilateral group. Sixteen of 54 eyes in the bilateral group were salvaged by systemic chemotherapy with local treatment. There was no difference in histopathological findings between the two groups. Nine of 57 patients in the unilateral group demonstrated poor outcomes, compared with four of 27 in the bilateral group. Significant poor prognostic factors for survival were optic nerve head invasion, orbital involvement, abnormal results on bone marrow aspiration, lumbar puncture, bone scan, and group E or F classification.
Conclusions
The 15% mortality rate in our patients is slightly higher than that reported in developed countries. Delayed diagnosis and treatment is the main cause of avoidable deaths. Improving education of both clinicians and parents would increase survival rates in this potentially fatal disease.
Similar content being viewed by others
References
Zelter M, Damel A, Gonzalez G, Schwartz L. A prospective study on the treatment of retinoblastoma in 72 patients. Cancer 1991;68:1685–1690.
Murphree AL, Villablanca JG, Deegan WF3rd, et al. Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol 1996;114:1348–1356.
Imhof SM, Moll AC, Schouten-van Meeteren AY. Intraocular retinoblastoma: new therapeutic options. Ned Tijdschr Geneeskd 2001;145:2165–2170.
Sussman DA, Escalona-Benz E, Benz MS, et al. Comparison of retinoblastoma reduction for chemotherapy vs external beam radiotherapy. Arch Ophthalmol 2003;21:979–984.
Lee TC, Hayashi NI, Dunkel IJ, Beaverson K, Novetsky D, Abramson DH. New retinoblastoma tumor formation in children initially treated with systemic carboplatin. Ophthalmology 2003; 110:1989–1994.
Atchaneeyasakul L, Murphree AL. Retinoblastoma. In: Ryan SJ, editor. Retina. Vol. 1. 3rd ed. St. Louis: Mosby; 2001. p. 513–570.
Altman DG. Practical statistics for medical research. 1st ed. London: Chapman & Hall; 1992.
Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. Am Stat Assoc J 1958;53:457–481.
Survival rate and risk factors for patients with retinoblastoma in Japan. The Committee for the National Registry of Retinoblastoma. Jpn J Ophthalmol 1992;36:121–131.
MacCarthy A, Draper GJ, Steliarova-Foucher E, Kingston JE. Retinoblastoma incidence and survival in European children (1978–1997). Report from the Automated Childhood Cancer Information System project. Eur J Cancer 2006;42:2092–2102.
Su WW, Kao LY. Retinoblastoma in Taiwan: the effect of a government-sponsored national health insurance program on the treatment and survival of patients with retinoblastoma. J Pediatr Ophthalmol Strabismus 2006;43:358–362.
Ozkan A, Pazarli H, Celkan T, et al. Retinoblastoma in Turkey: survival and clinical characteristics 1981–2004. Pediatr Int 2006;48:369–373.
Rubin CM, Robison LL, Cameron JD, et al. Intraocular Retinoblastoma Group V: an analysis of prognostic factors. J Clin Oncol 1985;3:680–685.
Shields CL, Shields JA, Baez K, Cater JR, De Potter P. Optic nerve invasion of retinoblastoma. Metastatic potential and clinical risk factors. Cancer 1994;73:692–698.
Khelfaoui F, Validire P, Auperin A, et al. Histopathologic risk factors in retinoblastoma: a retrospective study of 172 patients treated in a single institution. Cancer 1996;77:1206–1213.
Marback EF, Arias VE, Paranhos AJr, Soares FA, Murphree AL, Erwenne CM. Tumour angiogenesis as a prognostic factor for disease dissemination in retinoblastoma. Br J Ophthalmol 2003; 87:1224–1228.
Chong EM, Coffee RE, Chintagumpala M, Hurwitz RL, Hurwitz MY, Chévez-Barrios P. Extensively necrotic retinoblastoma is associated with high-risk prognostic factors. Arch Pathol Lab Med 2006;130:1669–1672.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Atchaneeyasakul, Lo., Wongsiwaroj, C., Uiprasertkul, M. et al. Prognostic factors and treatment outcomes of retinoblastoma in pediatric patients: a single-institution study. Jpn J Ophthalmol 53, 35–39 (2009). https://doi.org/10.1007/s10384-008-0614-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10384-008-0614-y